Protected: Secure Area

CDVAX is a project funded under the European Union 7th Framework. The aim of CDVAX is to take forward a novel and highly innovative vaccine that could provide protection to Clostridium difficile infection. The project will evaluate vaccines in a human clinical trial.

To learn more about Clostridium difficile and the illness it causes click here.

Professor Simon Cutting
Royal Holloway University of London
s.cutting@rhul.ac.uk